SONOMA PHARMACEUTICALS, INC. Proceeds from Unsecured Notes Payable
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Proceeds from Unsecured Notes Payable of $0 for the 9-month period ending 2021-12-31, per its 10-Q filed 2022-02-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromUnsecuredNotesPayable · last filed 2022-02-11
- 2021-12-31: Proceeds from Unsecured Notes Payable 9 month $0.00.
- 2020-12-31: Proceeds from Unsecured Notes Payable 9 month $1.31M.
| Period end | Proceeds from Unsecured Notes Payable 9 month |
|---|---|
| 2021-12-31 | $0.00 10-Q · filed 2022-02-11 |
| 2020-12-31 | $1.31M 10-Q · filed 2022-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |